Performance of Roche cobas high-risk human papillomavirus (hrHPV) testing in the two most common liquid-based Papanicolaou test platforms.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Society of Cytopathology"
DOI: 10.1016/j.jasc.2017.10.003
Abstract: INTRODUCTION High-risk human papillomavirus (hrHPV) testing is important in cervical cancer screening and management algorithms. Roche (Pleasanton, Calif.) cobas hrHPV testing is commonly performed on both ThinPrep (TP) and SurePath (SP) samples, but performance of… read more here.
Keywords: high risk; cytology; hrhpv testing; rate ... See more keywords
Cervical Cancer Screening in Postmenopausal Women: Is It Time to Move Toward Primary High-Risk Human Papillomavirus Screening?
Sign Up to like & getrecommendations! Published in 2021 at "Journal of women's health"
DOI: 10.1089/jwh.2020.8849
Abstract: Background: Cervical cytology in postmenopausal women is challenging due to physiologic changes of the hypoestrogenic state. Misinterpretation of an atrophic smear as atypical squamous cells of uncertain significance (ASCUS) is one of the most common… read more here.
Keywords: high risk; cytology; hrhpv testing; postmenopausal women ... See more keywords
Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.01443-19
Abstract: The objective was to assess the diagnostic test accuracy of high-risk human papillomavirus (hrHPV) testing of self-collected urine and cervicovaginal samples for the detection of cervical intraepithelial neoplasia grade 2 or higher (CIN2+). We recruited… read more here.
Keywords: test accuracy; human papillomavirus; detection cervical; hrhpv testing ... See more keywords